Market Overview

UPDATE: Bank of America Upgrades Molina Healthcare to Neutral on Stronger Revenue Trajectory

Share:
Related MOH
Regardless Of Election Results, Bloomberg And Goldman Sachs Say Buy Stocks Linked To Federal Spending
Goldman Gives Molina Healthcare A Checkup, Upgrades To Neutral
Healthcare ratings roundup - upgrades/downgrades (Seeking Alpha)

Bank of America raised its rating on Molina Healthcare (NYSE: MOH) from Underperform to Neutral and raised its price objective from $23 to $29.

Bank of America commented, "We are upgrading MOH shares to Neutral (from Underperform) with a view that companies with Medicaid exposure should benefit from coverage expansions outlined in health care reform legislation. Specifically, the market is likely to refocus on revenue growth driven by states transitioning existing beneficiaries to HMOs (from unmanaged fee for service), dual eligible demonstrations and program enrollment that could increase 20% starting in 2014 as projected by the CBO. We are raising our P.O. to $29 (from $23) on P/E multiple expansion."

Molina Healthcare closed at $26.62 on Tuesday.

Latest Ratings for MOH

DateFirmActionFromTo
Sep 2016Goldman SachsUpgradesSellNeutral
Sep 2016JefferiesMaintainsBuy
Aug 2016BarclaysTerminatesEqual-weight

View More Analyst Ratings for MOH
View the Latest Analyst Ratings

Posted-In: Bank of AmericaAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (MOH)

View Comments and Join the Discussion!